These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25090277)

  • 21. Transdermal delivery systems.
    Merkle HP
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):135-53. PubMed ID: 2657273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging strategies for the transdermal delivery of peptide and protein drugs.
    Schuetz YB; Naik A; Guy RH; Kalia YN
    Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Function of nanoparticles in transdermal and transmucosal drug delivery systems].
    Li J; Dong AJ
    Zhongguo Zhong Yao Za Zhi; 2004 Mar; 29(3):193-6. PubMed ID: 15706836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
    Li G; Badkar A; Nema S; Kolli CS; Banga AK
    Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination.
    Hegde NR; Kaveri SV; Bayry J
    Drug Discov Today; 2011 Dec; 16(23-24):1061-8. PubMed ID: 21782969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine.
    Nayak A; Das DB
    Biotechnol Lett; 2013 Sep; 35(9):1351-63. PubMed ID: 23690030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix.
    Tomalia DA
    Nanomedicine (Lond); 2012 Jul; 7(7):953-6. PubMed ID: 22846090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal delivery of desmopressin using a coated microneedle array patch system.
    Cormier M; Johnson B; Ameri M; Nyam K; Libiran L; Zhang DD; Daddona P
    J Control Release; 2004 Jul; 97(3):503-11. PubMed ID: 15212882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives on the draft ICH M10 guidance: an interview with Kelly Dong.
    Dong K
    Bioanalysis; 2019 Nov; 11(22):2025-2026. PubMed ID: 31645114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs).
    Shah UU; Roberts M; Orlu Gul M; Tuleu C; Beresford MW;
    Int J Pharm; 2011 Sep; 416(1):1-11. PubMed ID: 21767621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan microneedle patches for sustained transdermal delivery of macromolecules.
    Chen MC; Ling MH; Lai KY; Pramudityo E
    Biomacromolecules; 2012 Dec; 13(12):4022-31. PubMed ID: 23116140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
    Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling transdermal delivery of high molecular weight drugs from microneedle systems.
    Al-Qallaf B; Das DB; Mori D; Cui Z
    Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2951-67. PubMed ID: 17890186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic characteristics of formulated alendronate transdermal delivery systems in rats and humans.
    Choi A; Gang H; Whang J; Gwak H
    Drug Deliv; 2010 May; 17(4):249-54. PubMed ID: 20214414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enterprises and challenges in diagnostics for precision medicine: an interview with Eddie Blair.
    Blair E; Raison C
    Expert Rev Mol Diagn; 2015; 15(12):1521-3. PubMed ID: 26560159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.